Correlation Between Aquestive Therapeutics and Ryanair Holdings

Can any of the company-specific risk be diversified away by investing in both Aquestive Therapeutics and Ryanair Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aquestive Therapeutics and Ryanair Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Aquestive Therapeutics and Ryanair Holdings PLC, you can compare the effects of market volatilities on Aquestive Therapeutics and Ryanair Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aquestive Therapeutics with a short position of Ryanair Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aquestive Therapeutics and Ryanair Holdings.

Diversification Opportunities for Aquestive Therapeutics and Ryanair Holdings

-0.06

Correlation Coefficient

Aquestive Therapeutics  Ryanair Holdings

Good diversification

The 3 months correlation between Aquestive and Ryanair is -0.06. Overlapping area represents the amount of risk that can be diversified away by holding Aquestive Therapeutics and Ryanair Holdings PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ryanair Holdings PLC and Aquestive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aquestive Therapeutics are associated (or correlated) with Ryanair Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ryanair Holdings PLC has no effect on the direction of Aquestive Therapeutics i.e., Aquestive Therapeutics and Ryanair Holdings go up and down completely randomly.

Pair Corralation between Aquestive Therapeutics and Ryanair Holdings

Given the investment horizon of 90 days Aquestive Therapeutics is expected to under-perform the Ryanair Holdings. In addition to that, Aquestive Therapeutics is 2.02 times more volatile than Ryanair Holdings PLC. It trades about -0.1 of its total potential returns per unit of risk. Ryanair Holdings PLC is currently generating about 0.03 per unit of volatility. If you would invest  4,444  in Ryanair Holdings PLC on September 17, 2024 and sell it today you would earn a total of  101.00  from holding Ryanair Holdings PLC or generate 2.27% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Aquestive Therapeutics  vs.  Ryanair Holdings PLC

Aquestive Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Aquestive Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Ryanair Holdings PLC

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Ryanair Holdings PLC are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong basic indicators, Ryanair Holdings is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Aquestive Therapeutics and Ryanair Holdings

The main advantage of trading using opposite Aquestive Therapeutics and Ryanair Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aquestive Therapeutics position performs unexpectedly, Ryanair Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ryanair Holdings will offset losses from the drop in Ryanair Holdings' long position.

The idea behind Aquestive Therapeutics and Ryanair Holdings PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.